用於抗血管生成和癌症治療的α5β1的拮抗劑的給藥

• 收藏
• 分享

专利权人:

CALIFORNIA NORTHSTATE COLLEGE OF PHARMACY LLC

发明人:

FENG XIAODONG

申请号：

HK15104052.0

公开号：

HK1203391A

申请日:

2015.04.27

申请国别(地区):

HK

年份:

2015

代理人:

摘要：

A combination therapy is provided and is directed to pharmaceutical compositions and methods for administering a combination of an &alpha；5&bgr；1 antagonist with an &alpha；2&bgr；1 antagonist to a subject. The methods are for use in inhibiting, preventing, or reversing angiogenesis, as well as in treating cancer. The compositions and methods include a combined administration of VLO4 and VP12 (ECL12).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/